Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 13, 2017 - Issue 4
Submit an article Journal homepage
204
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series

Carrie YeungDivision of Medical Oncology, University of Toronto, Toronto, ON, CanadaView further author information
,
Teresa M. PetrellaDivision of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaView further author information
,
Frances C. WrightDivision of Surgical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaView further author information
,
Wadid AbadirDivision of Dermatology, University of Toronto, Toronto, ON, CanadaView further author information
&
Nicole J. Look HongDivision of Surgical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
View further author information
Pages 383-388 | Received 30 Oct 2016, Accepted 23 Jan 2017, Published online: 06 Feb 2017

References

  • Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics 2015 special topic: predictions of the future burden of cancer in Canada. Toronto (ON): Canadian Cancer Society; 2015.
  • Howlader N. SEER cancer statistics review, 1975-2013. Bethesda (MD): National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
  • Byers BA, Temple-Oberle CF, Hurdle V, et al. Treatment of in-transit melanoma with intra-lesional interluekin-2: a systematic review. J Surg Oncol. 2014;110:770–775.
  • Temple-Oberle CF, Byers BA, Hurdle V, et al. Intra-lesional Interleukin-2 therapy for in transit melanoma. J Surg Oncol. 2014;109:327–331.
  • Balch C. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–6206.
  • Gabriel E, Skitzki J. The role of regional therapies for in-transit melanoma in the era of improved systemic options. Cancers. 2015;7:1154–1177.
  • Ascierto ML, Melero I, Ascierto PA. Melanoma: from incurable beast to a curable bet. The success of immunotherapy. Front Oncol. 2015;5:152.
  • Thompson JF, Hersey P, Wachter E. Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Res. 2008;18:105–111.
  • Hassan S, Petrella TM, Zhang T, et al. Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit disease. Ann Surg Oncol. 2015;22:1950–1958.
  • Pires MC, Martins JM, Montealegre F, et al. Vitiligo after diphencyprone for alopecia areata. Dermatol Res Pract. 2010;2010:171265.
  • Aghaei S. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol. 2005;5:6.
  • Harland CC, Saihan EM. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine. Lancet. 1989;334(8660):445.
  • Damian DL, Shannon KF, Saw RP, et al. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australas J Dermatol. 2009;50:266–271.
  • Kim YJ. Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma. Ann Dermatol. 2012;24:373–375.
  • Trefzer U, Sterry W. Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma. Dermatology. 2005;211:370–371.
  • Trowbridge RM, Mitkov MV, Pittelkow MR, et al. Immunomodulation of malignant melanoma by contact sensitizing agents. Expert Rev Clin Immunol. 2014;10:63–76.
  • Martiniuk F, Damian DL, Thompson JF, et al. TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. J Drugs Dermatol. 2010;9:1368–1372.
  • Damian DL, Saw RP, Thompson JF. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma. J Surg Oncol. 2014;109:308–313.
  • Moncrieff M, Fadhil M, Garioch J. Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience. Br J Dermatol. 2016;174:1141–1142.
  • National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. May 29, 2009. version 4.03. NIH Publication. #09-7473.
  • Askew RL, Xing Y, Palmer JL, et al. Evaluating minimal important differences for the FACT-melanoma quality of life questionnaire. Value Health. 2009;12:1144–1150.
  • Bagge AS, Ben-Shabat I, Belgrano V, et al. Health-related quality of life for patients who have in-transit melanoma metastases treated with isolated limb perfusion. Ann Surg Oncol. 2016;23:2062–2069.
  • Ross MI. Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma. J Surg Oncol. 2014;109:314–319.
  • Morton DL, Eilber FR, Holmes EC, et al. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg. 1974;180:635–643.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.